Japanese Generic Drug Company Nichi-Iko Pharma Pruchases Sagent Pharma For $736M


Nichi-Iko Pharma, which is based in Japan, has purchased Sagent Pharma for $736 million. The agreement has already been approved by the Board of Directors for both companies. Nichi-Iko made the deal in order to enhance its biosimilar pipeline and improve its injectables presence. Nichi-Iko also hopes the deal will help the company to gain a stronger foothold in the US market.

Read the source article at NASDAQ.com

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>